title: [Pathogenetic and therapeutic aspects of secondary anorexia].
abstract: Anorexia is an often underrated symptom in the clinical management of patients suffering from chronic diseases. Moreover, the anorexia accompanying chronic diseases (secondary anorexia) is often confused with anorexia nervosa, a typically neuropsychiatric disorder involving completely different pathogenic mechanisms and therapeutic strategies. Secondary anorexia is one of the main factors responsible for the development of malnutrition, which in turn negatively affects patient morbidity and mortality. Different mechanisms have been proposed to explain the pathogenesis of secondary anorexia. However, consistent experimental and clinical evidence seems to point to hypothalamic serotonergic system hyperactivity as a preeminent cause; this hyperactivity appears to be triggered by enhanced brain availability of tryptophan, the aminoacid precursor of serotonin. The hyperactive hypothalamic serotonergic system might also represent the final effector where different regulatory and modulating pathways, including cytokines, converge. The involvement of tryptophan and the hypothalamic serotonergic system is further supported by the effectiveness of a therapeutic strategy, based on the inhibition of tryptophan entry into the brain, in increasing the food intake of anorectic patients. Although these results represent an encouraging approach to the treatment of secondary anorexia, with possible beneficial effects on the nutritional status of patients, they need to be validated in larger trials.
authors.forename: A
authors.initials: A
authors.lastname: Laviano
authors.forename: A
authors.initials: A
authors.lastname: Cascino
authors.forename: M
authors.initials: M
authors.lastname: Muscaritoli
authors.forename: F
authors.initials: F
authors.lastname: Rossi Fanelli
mesh_terms: D000293:Adolescent; D000328:Adult; D000597:Amino Acids, Branched-Chain / Q000627:therapeutic use; D000818:Animals; D000855:Anorexia / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000856:Anorexia Nervosa / Q000175:diagnosis / Q000209:etiology; D001812:Blood-Brain Barrier / Q000502:physiology; D001921:Brain / Q000378:metabolism / Q000502:physiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000502:physiology; D003937:Diagnosis, Differential; D004435:Eating; D002149:Energy Intake; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D009748:Nutrition Disorders / Q000209:etiology; D009752:Nutritional Status; D012701:Serotonin / Q000502:physiology; D014364:Tryptophan / Q000037:antagonists & inhibitors / Q000097:blood / Q000502:physiology
chemical_list: D000597:Amino Acids, Branched-Chain; D016207:Cytokines; D012701:Serotonin; D014364:Tryptophan